277 related articles for article (PubMed ID: 25972538)
1. Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.
Bai Y; Xuan B; Liu H; Zhong J; Yu D; Qian Z
J Virol; 2015 Aug; 89(15):7625-35. PubMed ID: 25972538
[TBL] [Abstract][Full Text] [Related]
2. The human cytomegalovirus protein pUL38 suppresses endoplasmic reticulum stress-mediated cell death independently of its ability to induce mTORC1 activation.
Qian Z; Xuan B; Gualberto N; Yu D
J Virol; 2011 Sep; 85(17):9103-13. PubMed ID: 21715486
[TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex.
Moorman NJ; Cristea IM; Terhune SS; Rout MP; Chait BT; Shenk T
Cell Host Microbe; 2008 Apr; 3(4):253-62. PubMed ID: 18407068
[TBL] [Abstract][Full Text] [Related]
4. Human Cytomegalovirus Protein pUL38 Prevents Premature Cell Death by Binding to Ubiquitin-Specific Protease 24 and Regulating Iron Metabolism.
Sun Y; Bao Q; Xuan B; Xu W; Pan D; Li Q; Qian Z
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695420
[TBL] [Abstract][Full Text] [Related]
5. The Human Cytomegalovirus UL38 protein drives mTOR-independent metabolic flux reprogramming by inhibiting TSC2.
Rodríguez-Sánchez I; Schafer XL; Monaghan M; Munger J
PLoS Pathog; 2019 Jan; 15(1):e1007569. PubMed ID: 30677091
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus UL38 protein blocks apoptosis.
Terhune S; Torigoi E; Moorman N; Silva M; Qian Z; Shenk T; Yu D
J Virol; 2007 Apr; 81(7):3109-23. PubMed ID: 17202209
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.
Savaryn JP; Reitsma JM; Bigley TM; Halligan BD; Qian Z; Yu D; Terhune SS
J Virol; 2013 Mar; 87(5):2463-74. PubMed ID: 23236067
[TBL] [Abstract][Full Text] [Related]
8. TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy.
García-Aguilar A; Guillén C; Nellist M; Bartolomé A; Benito M
Biochim Biophys Acta; 2016 Nov; 1863(11):2658-2667. PubMed ID: 27542907
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus protein pUL38 induces ATF4 expression, inhibits persistent JNK phosphorylation, and suppresses endoplasmic reticulum stress-induced cell death.
Xuan B; Qian Z; Torigoi E; Yu D
J Virol; 2009 Apr; 83(8):3463-74. PubMed ID: 19193809
[TBL] [Abstract][Full Text] [Related]
10. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.
Agarwal S; Bell CM; Taylor SM; Moran RG
Mol Cancer Res; 2016 Jan; 14(1):66-77. PubMed ID: 26385560
[TBL] [Abstract][Full Text] [Related]
11. Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123).
Crowell B; Lee GH; Nikolaeva I; Dal Pozzo V; D'Arcangelo G
eNeuro; 2015; 2(6):. PubMed ID: 26693177
[TBL] [Abstract][Full Text] [Related]
12. Differential IKK/NF-κB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous Sclerosis Complex Tumor Cells.
Gao Y; Gartenhaus RB; Lapidus RG; Hussain A; Zhang Y; Wang X; Dan HC
Mol Cancer Res; 2015 Dec; 13(12):1602-14. PubMed ID: 26374334
[TBL] [Abstract][Full Text] [Related]
13. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
[TBL] [Abstract][Full Text] [Related]
14. mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.
Taneike M; Nishida K; Omiya S; Zarrinpashneh E; Misaka T; Kitazume-Taneike R; Austin R; Takaoka M; Yamaguchi O; Gambello MJ; Shah AM; Otsu K
PLoS One; 2016; 11(3):e0152628. PubMed ID: 27023784
[TBL] [Abstract][Full Text] [Related]
15. Loss of TSC2 confers resistance to ceramide and nutrient deprivation.
Guenther GG; Liu G; Ramirez MU; McMonigle RJ; Kim SM; McCracken AN; Joo Y; Ushach I; Nguyen NL; Edinger AL
Oncogene; 2014 Apr; 33(14):1776-87. PubMed ID: 23604129
[TBL] [Abstract][Full Text] [Related]
16. High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null setting.
Medvetz D; Sun Y; Li C; Khabibullin D; Balan M; Parkhitko A; Priolo C; Asara JM; Pal S; Yu J; Henske EP
Mol Cancer Res; 2015 Jan; 13(1):50-62. PubMed ID: 25185584
[TBL] [Abstract][Full Text] [Related]
17. Tuberin activates and controls the distribution of Rac1 via association with p62 and ubiquitin through the mTORC1 signaling pathway.
Okura H; Kobayashi T; Koike M; Ohsawa M; Zhang D; Arai H; Uchiyama Y; Hino O
Int J Oncol; 2013 Aug; 43(2):447-56. PubMed ID: 23759924
[TBL] [Abstract][Full Text] [Related]
18. Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway.
Kawano H; Ito Y; Kanai F; Nakamura E; Tada N; Takai S; Horie S; Kobayashi T; Hino O
Oncol Rep; 2015 Nov; 34(5):2251-8. PubMed ID: 26352760
[TBL] [Abstract][Full Text] [Related]
19. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
[TBL] [Abstract][Full Text] [Related]
20. Peptide combinatorial libraries identify TSC2 as a death-associated protein kinase (DAPK) death domain-binding protein and reveal a stimulatory role for DAPK in mTORC1 signaling.
Stevens C; Lin Y; Harrison B; Burch L; Ridgway RA; Sansom O; Hupp T
J Biol Chem; 2009 Jan; 284(1):334-344. PubMed ID: 18974095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
